Monte Rosa Therapeutics (GLUE)'s 30-day implied volatility (IV30) was 62.9% at the close on November 13, 2026, down from 63.1% the day before, against a 52-week range of 41.2% to 139.4%. Its 20-day historical volatility was 65.7%.
Data as of November 13, 2026.